COMPARISON OF APPROVAL DATES OF NEW SUBSTANCES BETWEEN THE UNITED STATES OF AMERICA (FOOD AND DRUG ADMINISTRATION, FDA) AND EUROPE (EUROPEAN MEDICINES AGENCY, EMA)

被引：0
|
作者：
Batscheider, A. [1 ]
Weiss, K. [2 ]
Schnauffer, D. [3 ]
Al-Khalaf, A. [3 ]
Greiner, R. A. [3 ]
Shlaen, E. [3 ]
机构：
[1] IQVIA Commercial GmbH & Co OHG, Munich, BY, Germany
[2] IQVIA Commercial GmbH & Co OHG, Munich, Bavaria, Germany
[3] IQVIA Commercial GmbH & Co OHG, Munich, Germany
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PT25
引用
收藏
页码：S293 / S293
页数：1
相关论文
共 48 条
  • [1] A COMPARISON OF THE UNITED STATES' FDA APPROVAL PROCESS AND EUROPEAN EMA APPROVAL PROCESS
    Fletes, F. J.
    Kwak, E.
    Vanet, J.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [2] Time intervals between US Food and Drug Administration (FDA) and European Medicines Agency (EMA) new cancer therapy approvals.
    Lythgoe, Mark
    Krell, Jonathan
    Warner, Jeremy Lyle
    Desai, Aakash
    Khaki, Ali Raza
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] The Food and Drug Administration (FDA) and the European Medicines Agency (EMA) perspective on cardiovascular Polypill: A multidimensional concept
    Mogielnicki, Mariusz
    Swieczkowski, Damian
    Bachorski, Witold
    Zuk, Grzegorz
    Gilis-Malinowska, Natasza
    Zarzeka, Aleksander
    Merks, Piotr
    Gruchala, Marcin
    Jaguszewski, Milosz
    CARDIOLOGY JOURNAL, 2016, 23 (05) : 515 - 517
  • [4] Antineoplastic drug approvals by European Medicines Agency (EMA) and Food and Drug Administration (FDA) between 2018-2021. Evaluation of potential differences
    Alcubilla, P.
    Arellano, L.
    Aparicio, L.
    Burunat, L.
    Sanchez, C.
    Saez-Penataro, J.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (SUPPL 1) : S19 - S19
  • [5] Impact of the Food and Drug Administration (FDA)-European Medicines Agency (EMA) Common Commentary (CC) on Paediatric Cancer Drug Development
    Reaman, G.
    Herold, R.
    Norga, K.
    Donoghue, M.
    Casey, D.
    Chuk, M.
    Dinndorf, P.
    Leighton, J.
    Sterba, J.
    Paulo, P.
    Baiardi, P.
    van den Berg, H.
    Carleer, J.
    Suzanne, M.
    Temeck, J.
    Murphy, D.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S212 - S212
  • [6] Approval Timelines for Advanced Therapeutics in Inflammatory Bowel Disease: A Comparison Between the European Medicines Agency and the Food and Drug Administration
    Hanzel, Jurij
    Ma, Christopher
    De Silva, Theshani Amalka
    Alphonsus, Lotus
    Guizzetti, Leonardo
    Crowley, Eileen
    Singh, Siddharth
    Jairath, Vipul
    INFLAMMATORY BOWEL DISEASES, 2023, 30 (07) : 1211 - 1214
  • [7] Comparison of Good Clinical Practice Inspection Processes for Marketing Applications Between the United States Food and Drug Administration and the European Medicines Agency
    Ayalew, Kassa
    Ning, Yang-Min
    Foringer, Michelle J.
    Leibenhaut, Susan
    Sellers, Jenn W.
    Yu, Bei
    Kronstein, Phillip D.
    Higgerson, Agata
    Mihaescu, Camelia
    Rodriguez, Miguel
    Williams, LaKisha
    Khin, Ni A.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2023, 57 (01) : 79 - 85
  • [8] Comparison of Good Clinical Practice Inspection Processes for Marketing Applications Between the United States Food and Drug Administration and the European Medicines Agency
    Kassa Ayalew
    Yang-Min Ning
    Michelle J. Foringer
    Susan Leibenhaut
    Jenn W. Sellers
    Bei Yu
    Phillip D. Kronstein
    Agata Higgerson
    Camelia Mihaescu
    Miguel Rodriguez
    LaKisha Williams
    Ni A. Khin
    Therapeutic Innovation & Regulatory Science, 2023, 57 : 79 - 85
  • [9] Analysis of the Gene Therapies Authorized by the United States Food and Drug Administration and the European Medicines Agency
    Ghanem, Buthainah
    Seoane-Vazquez, Enrique
    Brown, Lawrence
    Rodriguez-Monguio, Rosa
    MEDICAL CARE, 2023, 61 (07) : 438 - 447
  • [10] Pediatric Cancer Studies Triggered by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) Aim at Labels, Not at Improved Treatment
    Rose, K.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S361 - S362
12345